Description
Recaticimab Biosimilar - Anti-PCSK9 mAb - Research Grade
Target
PCSK9
Target Alias Name
Recaticimab/IMMUNOGLOBULIN G1-KAPPA/ ANTI-(HOMO SAPIENSPCSK9 (PROPROTEIN CONVERTASE SUBTILISIN/KEXIN TYPE 9/ NEURAL APOPTOSIS-REGULATED CONVERTASE 1/ NARC1/ NARC-1/ PROPROTEINE CONVERTASE 9/ PC9))/ MONOCLONAL ANTIBODY (RECATICIMAB)/PCSK9/anti-PCSK9
Isotype/Mimetic
IgG1/Kappa
Animal-Derived Biomaterials Used
None
Sequence Available
No
Original Discovery Method
Unknown
Original Discovery Information Provided On Datasheet
No
Antibody/Binder Origins
Unknown discovery source/method, In vitro recombinant expression